RespireRx Pharmaceuticals Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 0.430063 million compared to USD 0.860163 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0009 USD | -18.18% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 697K | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- RSPI Stock
- News RespireRx Pharmaceuticals Inc.
- RespireRx Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023